Genomic imbalances in ovarian borderline serous and mucinous tumors

Cancer Genetics and Cytogenetics

Volumn 139, Issue 1, 2002, Pages 18-23

  Hu, Jie ^a,b   Khanna, Vinish ^b   Jones, Mirka M W ^b   Surti, Urvashi ^b,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CHROMOSOME 8; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY TUMOR; PRIORITY JOURNAL; X CHROMOSOME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; ALLELIC IMBALANCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, X; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 0036873742     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00603-9     Document Type: Article

References (22)

1. Stevens A., Lowe J. Gynaecological and obstetric Pathology. Stevens A., Lowe J. Pathology. 1995;361-386 Mosby, London.
2. Kurman R.J., Trimble C.L. The behavior of serous tumors of low malignant potential. are they ever malignant? Int J Gynecol Pathol. 12:1993;120-127.
3. Wolf N.G., Abdul-Karim F.W., Farver C., Schrock E., du Manoir S., Schwartz S. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer. 25:1999;307-315.
4. Knoerr-Gaerytner H., Schuhmann R., Kraus H., Uebele-Kallhardt B. Comparative cytogenetic and histologic studies on early malignant transformation in mesothelial tumors of the ovary. Hum Genet. 35:1997;281-297.
5. Crickard K., Marinello M.J., Crickard U., Satchidanand S.K., Yoonessi M., Caglar H. Borderline malignant serous tumors of the ovary maintained on extracellular matrix. evidence for clonal evolution and invasive potential Cancer Genet Cytogenet. 23:1986;135-143.
6. Tharapel S.A., Qumsiyeh M.B., Photopulos G. Numerical chromosome abnormalities associated with early clinical stages of gynecologic tumors. Cancer Genet Cytogenet. 55:1991;89-96.
7. Yang-Feng T.L., Li S.B., Leung W.Y., Carcangiu M.L., Schwartz P.E. Trisomy 12 and K-ras-2 amplification in human ovarian tumors. Int J Cancer. 48:1991;678-681.
8. Thompson F.H., Liu Y., Emerson J., Weinstein R., Makar R., Trent J.M., Taetle R., Alberts D.S. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma. Genes Chromosomes Cancer. 10:1994;262-266.
9. Pejovic T., Iosif C.S., Mitelman F., Heim S. Karyotypic characteristics of borderline malignant tumors of the ovary. trisomy 12, trisomy 7, and r(1) as nonrandom features Cancer Genet Cytogenet. 92:1996;95-98.
10. Deger R.B., Faruqi S.A., Noumoff J.S. Karyotypic analysis of 32 malignant epithelial ovarian tumors. Cancer Genet Cytogenet. 96:1997;166-173.
11. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer. 16:1996;46-54.
12. Sonoda G., Palazzo J., du Manoir S., Godwin A.K., Feder M., Yakushiji M., Testa J.R. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer. 20:1997;320-328.
13. Blegen H., Einhorn N., Sjovall K., Roschke A., Ghadimi B.M., McShane L.M., Nilsson B., Shah K., Ried T., Auer G. Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. Int J Gynecol Cancer. 10:2000;477-487.
14. Tapper J., Butzow R., Wahlstrom T., Seppala M., Knuutila S. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas. Br J Cancer. 75:1997;1782-1787.
15. Jenkins R.B., Bartelt D. Jr., Stalboerger P., Persons D., Dahl R.J., Podratz K., Keeney G., Hartmann L. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet. 71:1993;76-86.
16. Izutsu T., Kudo T., Shoji T., Nishiya I. Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors. J Obstet Gynaecol Res. 22:1996;541-549.
17. Yu Y., Xu F., Peng H., Fang X., Zhao S., Li Y., Cuevas B., Kuo W.L., Gray J.W., Siciliano M., Mills G.B., Bast R.C. Jr. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA. 96:1999;214-219. [Free in PMC].
18. Caron H., Spieker N., Godfried M., Veenstra M., van Sluis P., de Kraker J., Voute P., Versteeg R. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer. 30:2001;168-174.
19. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y.Y., Carcangui M.L., Pinkel D., Yang-Feng T.L., Gray J.W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:1995;6172-6180.
20. Kiechle M., Jacobsen A., Schwarz-Boeger U., Hedderich J., Pfisterer J., Arnold N. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation. Cancer. 91:2001;534-540.
21. Buller R.E., Sood A.K., Lallas T., Buekers T., Skilling J.S. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst. 17:1999;339-346.
22. Park T.W., Felix J.C., Wright T.C. Jr. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas. Cancer Res. 55:1995;4793-4796.